Sernova Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 25, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	2016 - 2020
Market Capitalization	49	58	176	172	263	41	Upgrade
Market Cap Growth	-50.00%	-66.76%	2.10%	-34.68%	534.77%	43.04%	Upgrade
Enterprise Value	51	55	153	141	239	41	Upgrade
Last Close Price	0.14	0.18	0.57	0.59	0.99	0.20	Upgrade
PB Ratio	-3.29	-6.28	19.49	4.93	11.63	13.32	Upgrade
P/TBV Ratio	-	-	19.99	4.98	11.93	17.10	Upgrade
Debt / Equity Ratio	-0.23	-0.04	0.01	0.01	0.01	0.17	Upgrade
Quick Ratio	0.10	0.32	2.17	10.74	19.19	5.08	Upgrade
Current Ratio	0.13	0.32	2.19	10.78	19.19	5.25	Upgrade
Return on Equity (ROE)	-	-	-129.72%	-64.54%	-43.25%	-117.90%	Upgrade
Return on Assets (ROA)	-167.56%	-133.56%	-67.87%	-37.59%	-24.39%	-58.21%	Upgrade
Return on Capital (ROIC)	-	-14992.87%	-83.63%	-40.53%	-26.03%	-67.58%	Upgrade
Earnings Yield	-32.36%	-39.58%	-15.99%	-10.41%	-2.13%	-9.64%	Upgrade
FCF Yield	-	-23.23%	-12.48%	-6.29%	-2.10%	-7.15%	Upgrade
Buyback Yield / Dilution	-5.24%	-1.19%	-10.87%	-11.43%	-24.45%	-12.17%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.